Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI

Abstract Parkinson’s disease (PD) is a neurodegenerative synucleinopathy characterized by the degeneration of neuromelanin (NM)-containing dopaminergic neurons and deposition of iron in the substantia nigra (SN). How regional NM loss and iron accumulation within specific areas of SN relate to nigro-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Frédérique Depierreux, Eric Parmentier, Laurane Mackels, Katherine Baquero, Christian Degueldre, Evelyne Balteau, Eric Salmon, Christophe Phillips, Mohamed Ali Bahri, Pierre Maquet, Gaëtan Garraux
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/0946553028454154b53ef1778f32be08
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0946553028454154b53ef1778f32be08
record_format dspace
spelling oai:doaj.org-article:0946553028454154b53ef1778f32be082021-12-02T15:39:42ZParkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI10.1038/s41531-021-00199-22373-8057https://doaj.org/article/0946553028454154b53ef1778f32be082021-07-01T00:00:00Zhttps://doi.org/10.1038/s41531-021-00199-2https://doaj.org/toc/2373-8057Abstract Parkinson’s disease (PD) is a neurodegenerative synucleinopathy characterized by the degeneration of neuromelanin (NM)-containing dopaminergic neurons and deposition of iron in the substantia nigra (SN). How regional NM loss and iron accumulation within specific areas of SN relate to nigro-striatal dysfunction needs to be clarified. We measured dopaminergic function in pre- and postcommissural putamen by [18F]DOPA PET in 23 Parkinson’s disease patients and 23 healthy control (HC) participants in whom NM content and iron load were assessed in medial and lateral SN, respectively, by NM-sensitive and quantitative R2* MRI. Data analysis consisted of voxelwise regressions testing the group effect and its interaction with NM or iron signals. In PD patients, R2* was selectively increased in left lateral SN as compared to healthy participants, suggesting a local accumulation of iron in Parkinson’s disease. By contrast, NM signal differed between PD and HC, without specific regional specificity within SN. Dopaminergic function in posterior putamen decreased as R2* increased in lateral SN, indicating that dopaminergic function impairment progresses with iron accumulation in the SN. Dopaminergic function was also positively correlated with NM signal in lateral SN, indicating that dopaminergic function impairment progresses with depigmentation in the SN. A complex relationship was detected between R2* in the lateral SN and NM signal in the medial SN. In conclusion, multimodal imaging reveals regionally specific relationships between iron accumulation and depigmentation within the SN of Parkinson’s disease and provides in vivo insights in its neuropathology.Frédérique DepierreuxEric ParmentierLaurane MackelsKatherine BaqueroChristian DegueldreEvelyne BalteauEric SalmonChristophe PhillipsMohamed Ali BahriPierre MaquetGaëtan GarrauxNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 7, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurology. Diseases of the nervous system
RC346-429
Frédérique Depierreux
Eric Parmentier
Laurane Mackels
Katherine Baquero
Christian Degueldre
Evelyne Balteau
Eric Salmon
Christophe Phillips
Mohamed Ali Bahri
Pierre Maquet
Gaëtan Garraux
Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
description Abstract Parkinson’s disease (PD) is a neurodegenerative synucleinopathy characterized by the degeneration of neuromelanin (NM)-containing dopaminergic neurons and deposition of iron in the substantia nigra (SN). How regional NM loss and iron accumulation within specific areas of SN relate to nigro-striatal dysfunction needs to be clarified. We measured dopaminergic function in pre- and postcommissural putamen by [18F]DOPA PET in 23 Parkinson’s disease patients and 23 healthy control (HC) participants in whom NM content and iron load were assessed in medial and lateral SN, respectively, by NM-sensitive and quantitative R2* MRI. Data analysis consisted of voxelwise regressions testing the group effect and its interaction with NM or iron signals. In PD patients, R2* was selectively increased in left lateral SN as compared to healthy participants, suggesting a local accumulation of iron in Parkinson’s disease. By contrast, NM signal differed between PD and HC, without specific regional specificity within SN. Dopaminergic function in posterior putamen decreased as R2* increased in lateral SN, indicating that dopaminergic function impairment progresses with iron accumulation in the SN. Dopaminergic function was also positively correlated with NM signal in lateral SN, indicating that dopaminergic function impairment progresses with depigmentation in the SN. A complex relationship was detected between R2* in the lateral SN and NM signal in the medial SN. In conclusion, multimodal imaging reveals regionally specific relationships between iron accumulation and depigmentation within the SN of Parkinson’s disease and provides in vivo insights in its neuropathology.
format article
author Frédérique Depierreux
Eric Parmentier
Laurane Mackels
Katherine Baquero
Christian Degueldre
Evelyne Balteau
Eric Salmon
Christophe Phillips
Mohamed Ali Bahri
Pierre Maquet
Gaëtan Garraux
author_facet Frédérique Depierreux
Eric Parmentier
Laurane Mackels
Katherine Baquero
Christian Degueldre
Evelyne Balteau
Eric Salmon
Christophe Phillips
Mohamed Ali Bahri
Pierre Maquet
Gaëtan Garraux
author_sort Frédérique Depierreux
title Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
title_short Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
title_full Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
title_fullStr Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
title_full_unstemmed Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
title_sort parkinson’s disease multimodal imaging: f-dopa pet, neuromelanin-sensitive and quantitative iron-sensitive mri
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/0946553028454154b53ef1778f32be08
work_keys_str_mv AT frederiquedepierreux parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
AT ericparmentier parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
AT lauranemackels parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
AT katherinebaquero parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
AT christiandegueldre parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
AT evelynebalteau parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
AT ericsalmon parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
AT christophephillips parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
AT mohamedalibahri parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
AT pierremaquet parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
AT gaetangarraux parkinsonsdiseasemultimodalimagingfdopapetneuromelaninsensitiveandquantitativeironsensitivemri
_version_ 1718385852614180864